Latest News

Companhia Brasileira de Alumínio's ( BVMF:CBAV3 ) stock was strong after they recently reported robust earnings...

Key Insights Quantum-Si's significant retail investors ownership suggests that the key decisions are influenced by...

Padtec Holding S.A. ( BVMF:PDTC3 ) shareholders have had their patience rewarded with a 28% share price jump in the...

The market for Lavvi Empreendimentos Imobiliários S.A.'s ( BVMF:LAVV3 ) stock was strong after it released a healthy...

Wondering if Keyera is undervalued or fairly priced? You are not alone, as many investors are taking a closer look at this stock's potential. In the past week, Keyera shares gained 5.7%, even though the stock is nearly flat over the past year and down 2.5% year-to-date. This recent momentum is all the more eye-catching. This price action comes after analysts and market watchers highlighted Keyera’s strategic midstream asset investments and a major infrastructure partnership announced earlier...

Innoviva, Inc. recently reported third-quarter 2025 earnings, showcasing a substantial year-over-year surge in both revenue, at US$107.8 million, and net income, at US$89.91 million, alongside the announcement of a new US$125 million share repurchase program with no set end date. This combination of robust financial performance and a significant buyback initiative highlights the company's strengthened financial position and management’s confidence in its future outlook. We'll explore how...

Plains GP Holdings, L.P. recently reported third quarter results, showing US$11.58 billion in sales and net income of US$83 million, both for the period ended September 30, 2025. Despite a decrease in sales compared to a year ago, the company's net income and earnings per share rose significantly, reflecting improved profitability. We'll explore how this higher net income, achieved even as sales declined, may influence Plains GP Holdings' long-term investment outlook. AI is about to change...

Ever wondered if LendingClub’s latest run-up means the stock is still a good deal, or if the ship has already sailed on value? Let’s take a closer look at what’s really happening beneath the surface before making that call. The stock has had quite the ride, climbing 15.5% over the past year and racking up a huge 151.3% gain over five years, even with a slight 5% pullback over the last week. Some of the excitement and volatility stems from recent headlines about fintech partnerships and...

Earlier this month, Reinsurance Group of America announced the opening of its first New York City office at Park Avenue Tower, reflecting a focus on high-quality assets and a people-first workplace in a premier Midtown Manhattan location. On the research front, RGA's recent study suggests that widespread adoption of GLP-1 medications could lower US mortality by 3.5% by 2045, underscoring potential long-term implications for population health and the insurance sector. We will examine how the...

Restaurant Brands International Limited Partnership (TSX:QSP.UN) stock has seen steady gains over the past month, catching the attention of investors looking for consistency. With these recent moves, it is a good moment to revisit the company’s ongoing performance and outlook. See our latest analysis for Restaurant Brands International Limited Partnership. The momentum in Restaurant Brands International Limited Partnership’s share price has picked up lately, reflecting renewed confidence as...

Perella Weinberg Partners recently reported third-quarter financial results that missed analyst expectations, with revenue declining due to softer mergers and acquisitions activity. Management emphasized a record level of active client engagements and highlighted that contributions from new hires and the Devon Park acquisition are anticipated mainly in 2026. We'll examine how leadership's outlook for future pipeline growth informs the company’s broader investment narrative amid recent...

Despite an already strong run, Direcional Engenharia S.A. ( BVMF:DIRR3 ) shares have been powering on, with a gain of...

Key Insights The considerable ownership by private companies in Trisul indicates that they collectively have a greater...

Tomra Systems (OB:TOM) drew attention after a regulatory filing revealed that Johan Hjertonsson, chairman and primary insider, purchased 10,000 additional shares. This move doubled his stake to 20,000 shares. Investors often watch insider activity for signals on management outlook and commitment. See our latest analysis for Tomra Systems. This insider buying comes after what has been a challenging stretch for Tomra Systems, with the share price sliding nearly 19% year-to-date and the one-year...

Lerøy Seafood Group recently reported mixed Q3 2025 results, with its Farming segment hindered by low salmon prices and biological issues, while its value-added processing, sales and distribution segment achieved record earnings. The company's investments in laser delousing and closed containment farming aim to boost sustainability and efficiency, as management anticipates a more balanced salmon market and lower production costs in the coming year. To assess how this impacts Lerøy's...

Lianlian DigiTech (SEHK:2598) has been catching some attention lately, with shares moving in various directions over the past week and month. Investors are weighing recent trading patterns in relation to the company’s overall financial trajectory. See our latest analysis for Lianlian DigiTech. Lianlian DigiTech’s share price has swung lower over the past quarter, with a 90-day share price return of -17.96% and a one-year total shareholder return of -13.4%. While momentum has faded recently,...

In recent weeks, Domino's Pizza Enterprises Limited (ASX:DMP) appointed Morgan Stanley as its defence adviser following private equity buyout speculation, with names like KKR and Bain Capital reportedly circling the business, although no direct discussions with Domino's have taken place. The company's Annual General Meeting brought increased transparency and strengthened governance, with key resolutions passed and efforts to improve franchisee profitability and operational performance...

Earlier this month, Cytek Biosciences reported third-quarter 2025 earnings, showing revenue of US$52.29 million and a net loss of US$5.48 million compared to net income in the prior year, and reaffirmed its full-year revenue guidance of US$196 million to US$205 million. This combination of improved quarterly revenue but a swing to quarterly and year-to-date losses provided investors with contrasting signals about Cytek’s ongoing financial health and outlook. We’ll review how the...

Atlas Copco (OM:ATCO A) shares have caught some attention this month as investors assess recent shifts in valuation. With its performance over the past month showing a small dip, there is renewed interest in what might lie ahead. See our latest analysis for Atlas Copco. Atlas Copco’s share price has pulled back over the past month, extending a trend that has seen a 9.7% decline year-to-date. While momentum has faded lately, the wider view reveals long-term holders are still well in the green...

Inhibrx Biosciences (INBX) shared that its Phase 2 trial for ozekibart in chondrosarcoma achieved its primary endpoint, showing a clear improvement in progression-free survival. The company now plans to move forward and submit a biologics license application to the FDA next year, an important step that reflects confidence in its trial results and future prospects. See our latest analysis for Inhibrx Biosciences. Inhibrx Biosciences’ journey over the past year reflects how powerful clinical...

Autolus Therapeutics (AUTL) just released its latest quarterly earnings and is drawing increased investor attention thanks to several key developments. The company continues to expand commercial access for Obe-cel, reports strong manufacturing results, and anticipates new data at the upcoming ASH conference. See our latest analysis for Autolus Therapeutics. Autolus Therapeutics has seen a burst of activity lately, from broadening commercial access and updating its leadership team to advancing...

Legence (LGN) shares have moved higher recently, catching investors’ attention after the company reported a strong annual net income improvement and steady revenue growth. The stock is up more than 20% over the past month. See our latest analysis for Legence. Legence’s 1-month share price return of 20.2% is grabbing attention, especially after its annual profit surge. Momentum appears to be building as confidence returns and investors increasingly factor in the company’s growth story. With...

Scorpio Tankers recently sold over 2.3 million shares in DHT Holdings, reducing its stake while still retaining 1,169,568 shares, and announced plans to expand its fleet by building two additional VLCCs in South Korea with Hanwha Ocean Co. Ltd. This shift in DHT's shareholder structure, driven by Scorpio Tankers' divestment and reinvestment in its own fleet growth, may influence market perspectives on both companies' future directions. We'll explore how Scorpio Tankers' decision to reduce...

Earlier this week, Genscript Biotech Corporation announced that its associate, Legend Biotech Corporation, reported a significant reduction in net losses for the third quarter of 2025, alongside strong sales growth for its CARVYKTI product. This disclosure, released around Genscript’s Analyst/Investor Day, places enhanced focus on the financial ties between the two companies and the implications for Genscript’s broader business outlook. We’ll now explore how Legend Biotech’s improved...